PieroMN,NzaroGM,Njagi JM, 2014.Diabetes mellitus a devastating metabolic disorder,Asian J Biomed Pharmaceu Sci 04 1 -7
AnsariRM,DixonJB, 2015.Coles J. Type 2 diabetes: Challenges to health care system of Pakistan,Intern J Diabetes Res 4 7 -12
ForbesJM,Cooper ME, 2013.Mechanisms of diabetic complications,Physiol Rev 93 137 -88
NyenweEA,JerkinsTW,UmpierreGE,KitabchiAE, 2011.Management of type 2 diabetes: Evolving strategies for the treatment of patients with type 2 diabetes,J Metabol 60 1 -23
Pathophysiologic approach to therapy in patients with newly diagnosed type 2 diabetes., -
DiabetesCare, 2013., 36 127 -8
ShinJM,Kim N, 2013.Pharmacokinetics and pharmacodynamics of the proton pump inhibitors,J Neurogasteroenterol Motil 19 25 -35
TakebayashiK,InukaiT., 2015.Effect of proton pump inhibitors on glycemic control in patients with diabetes,World J Diabetes 6 1122 -31
BarchettaI,GuglielmiC,BertocciniL,CalellaD,ManfriniS,SecchiC,PozzilliP,CavalloMG, 2015.Therapy with proton pump inhibitors in patients with type 2 diabetes is independently associated with improved glycometabolic control,Acta Diabetol 52 873 -80
CrouchMA,MeffordIN,WadeEU, 2012.Proton pump inhibitor therapy associated with lower glycosylated hemoglobin levels in type 2 diabetes,J Am Board Fam Med 25 50 -4
., -
InciF,AtmacaM,OzturkM,YildizS,KocerogluR,SekerogluR,IpekciSH,Kebapcilar, 2014.Pantoprazole may improve beta cell function and diabetes mellitus,JEndocrional Invest 37 449 -54
MeffordIN,WadeEU, 2009.Proton pump inhibitors as a treatment method for type II diabetes,Med Hypotheses 73 29 -32
SinghPK,HotaD,DuttaP,SachdevaN,ChakrabartiA,SrinivasanA,SinghI,BhansaliA, 2012.Pantoprazole improves glycemic control in type 2 diabetes: a randomized, double-blind, placebo-controlled trial,J Clin Endocrinol Metab 97 2105 -08
BödvarsdóttirTB,HoveKD,GotfredsenCF, 2010.Treatment with a proton pump inhibitor improves glycaemic control in Psammomys obesus, a model of type 2 diabetes,Diabetologia 53 2220 -23
Boj-CarcellerD,Bocos-TerrazP,MorenoVernisM,Sanz-ParisA,Trincado-AznarP,Albero-GamboaR, 2011.Are proton pump inhibitors a new anti-diabetic drug? A cross sectional study,World J Diabetes 2 217 -20
HanN,OhM,ParkSM,KimYJ,LeeEJ,KimTK,KimTN,KwonMJ,KimMK,LeeSH,RheeBD, 2015.ParkJH.The effect of proton pump inhibitors on glycated hemoglobin levels in patients with type2 diabetes mellitus, 24 -8
KoopH,KleinM,ArnoldR, 1990.Serum gastrin levels during long-term omeprazole treatment,Aliment Pharmacol Ther 4 131 -8
TéllezN,JoannyG,EscorizaJ,VilasecaM,MontanyaE., 2011.Gastrin treatment stimulates -cell regeneration and improves glucose tolerance in 95% pancreatectomized rats,Endocrinology 2 2580 -8
SanakaM,YamamotoT,KuyamaY., 2010.Effects of proton pump inhibitors on gastric emptying: a systematic review,Dig Dis Sci 55 2431 -40
HirstJA,FarmerAJ,DyarA,LungTWC,StevensRJ, 2013.Estimating the effect of sulfonylurea on HbA1c in diabetes: a systematic review and meta-analysis,Diabetologia 56 973 -84
RauTT,SonstA,RoglerA,BurnatG,NeumannH,OecklK,NeuhuberW,DimmlerA,FallerG,BrzozowskiT,HartmannA,KonturekPC, 2013.Gastrin mediated down regulation of ghrelin and its pathophysiological role in atrophic gastritis,J Physiol Pharmacol 64 719 -25
CaoY,CaoX,LiuXM, 2015.Expression of cholecystokinin-2 receptor in rat and human L cells and the stimulation of glucagon-like peptide-1 secretion by gastrin treatment,Acta Histochem 117 205 -21
KimA.,Chung,YoonSH,YuKS,LimKS,ChoJY,LeeH,JangIJ,ChungJY, 2014.Effects of proton pump inhibitors on metformin pharmacokinetics and pharmacodynamics,Drug Metab Dispos 42 1174 -9
AntoniouT,MacDonaldEM,HollandsS, 2015.Proton pump inhibitors and the risk of acute kidney injury in older patients: a population-based cohort study,CMAJ 3 166 -71
XieY,BoweB,LiT, 2016.Proton Pump Inhibitors and Risk of Incident CKD and Progression to ESRD,J Am Soc Nephrol 27 3153 -